心肌梗死通用定义在苏格兰和瑞典临床实践中的应用
该队列研究利用苏格兰(2013-2016年)和瑞典(2011-2014年)两个前瞻性连续纳入可能心梗患者的队列,评估临床记录的心梗诊断与独立专家组按心肌梗死通用定义判定的1型或2型心梗的一致性。结果显示,苏格兰临床诊断1型心梗2506/3187例(79%)、2型心梗122/716例(17%);瑞典分别为970/1111例(87%)和57/251例(23%)。未被临床诊断的1型心梗患者更多为女性且年龄更大,调整非心血管死亡竞争风险后,其后续心梗或心血管死亡风险与临床诊断心梗者相似或更高。作者认为,心肌梗死通用定义在临床实践中应用不一致,2型心梗多数未被识别,女性和老年人的1型心梗被低估。
要点
- 苏格兰临床诊断1型心梗2506/3187例(79%)、2型心梗122/716例(17%);瑞典分别为970/1111例(87%)和57/251例(23%)。
- 临床未诊断的1型心梗患者中女性比例更高(苏格兰336/686例,49% vs 909/2501例,36%;P < .001)。
- 临床未诊断的1型心梗患者年龄更大(苏格兰平均[SD]年龄71[14]岁 vs 67[14]岁;P < .001)。
- 调整非心血管死亡竞争风险后,临床未诊断的1型心梗患者后续心梗或心血管死亡风险与临床诊断者相似或更高(苏格兰29% vs 18%;P < .001)。
- 作者认为,心肌梗死通用定义在临床实践中应用不一致,对2型心梗的识别率低,对女性和老年人的1型心梗存在低估。
适用人群与场景
- 苏格兰(2013-2016年)和瑞典(2011-2014年)两个前瞻性队列中连续纳入的可能心梗患者,共50356例;苏格兰28783例(男性15562例,54%;平均[SD]年龄60[17]岁),瑞典21573例(男性11110例,51%;平均[SD]年龄56[17]岁)。
诊断标准与关键阈值
- 心肌梗死通用定义:1型心梗由动脉粥样血栓形成所致,2型心梗由心肌氧供需失衡所致;由独立专家组据此判定。
红旗征与不能漏的情况
- 临床未诊断的1型心梗患者中女性和老年人比例更高,且调整竞争风险后后续心梗或心血管死亡风险相似或更高(苏格兰29% vs 18%;P < .001)。
研究设计与关键结果
- 研究类型为队列研究,使用苏格兰和瑞典两个前瞻性队列数据,共评估50356例可能心梗患者。
- 苏格兰临床记录心梗诊断:1型心梗2506/3187例(79%),2型心梗122/716例(17%)。
- 瑞典临床记录心梗诊断:1型心梗970/1111例(87%),2型心梗57/251例(23%)。
- 临床未诊断的1型心梗患者更可能为女性(苏格兰336/686例,49% vs 909/2501例,36%;P < .001)且年龄更大(苏格兰平均[SD]年龄71[14]岁 vs 67[14]岁;P < .001)。
- 调整非心血管死亡竞争风险后,临床未诊断的1型心梗患者后续心梗或心血管死亡风险与临床诊断者相似或更高(苏格兰29% vs 18%;P < .001)。
证据类型、等级与局限
- 证据类型:队列研究(两个前瞻性队列)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,心肌梗死通用定义在临床实践中应用不一致,2型心梗仅少数被识别,女性和老年人的1型心梗被低估,提示对诊断标准或分类价值仍存在不确定性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Whether the diagnostic classifications proposed by the universal definition of myocardial infarction (MI) to identify type 1 MI due to atherothrombosis and type 2 MI due to myocardial oxygen supply-demand imbalance have been applied consistently in clinical practice is unknown.
OBJECTIVE: To evaluate the application of the universal definition of MI in consecutive patients with possible MI across 2 health care systems.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from 2 prospective cohorts enrolling consecutive patients with possible MI in Scotland (2013-2016) and Sweden (2011-2014) to assess accuracy of clinical diagnosis of MI recorded in hospital records for patients with an adjudicated diagnosis of type 1 or type 2 MI. Data were analyzed from August 2022 to February 2023.
MAIN OUTCOMES AND MEASURES: The main outcome was the proportion of patients with a clinical diagnosis of MI recorded in the hospital records who had type 1 or type 2 MI, adjudicated by an independent panel according to the universal definition. Characteristics and risk of subsequent MI or cardiovascular death at 1 year were compared.
RESULTS: A total of 50 356 patients were assessed. The cohort from Scotland included 28 783 (15 562 men [54%]; mean [SD] age, 60 [17] years), and the cohort from Sweden included 21 573 (11 110 men [51%]; mean [SD] age, 56 [17] years) patients. In Scotland, a clinical diagnosis of MI was recorded in 2506 of 3187 patients with an adjudicated diagnosis of type 1 MI (79%) and 122 of 716 patients with an adjudicated diagnosis of type 2 MI (17%). Similar findings were observed in Sweden, with 970 of 1111 patients with adjudicated diagnosis of type 1 MI (87%) and 57 of 251 patients with adjudicated diagnosis of type 2 MI (23%) receiving a clinical diagnosis of MI. Patients with an adjudicated diagnosis of type 1 MI without a clinical diagnosis were more likely to be women (eg, 336 women [49%] vs 909 women [36%] in Scotland; P < .001) and older (mean [SD] age, 71 [14] v 67 [14] years in Scotland, P < .001) and, when adjusting for competing risk from noncardiovascular death, were at similar or increased risk of subsequent MI or cardiovascular death compared with patients with a clinical diagnosis of MI (eg, 29% vs 18% in Scotland; P < .001).
CONCLUSIONS AND RELEVANCE: In this cohort study, the universal definition of MI was not consistently applied in clinical practice, with a minority of patients with type 2 MI identified, and type 1 MI underrecognized in women and older persons, suggesting uncertainty remains regarding the diagnostic criteria or value of the classification.
参考来源
- Taggart C, Roos A, Kadesjö E, et al. Application of the Universal Definition of Myocardial Infarction in Clinical Practice in Scotland and Sweden. JAMA Netw Open. 2024. PMID: 38587840. doi:10.1001/jamanetworkopen.2024.5853
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。